Brainstorm Cell Valuation
| BCLI Stock | USD 1.74 0.12 7.41% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Brainstorm Cell Ther shows a prevailing Real Value of $1.67 per share. The current price of the firm is $1.74. Our model approximates the value of Brainstorm Cell Ther from analyzing the firm fundamentals such as current valuation of 10.6 M, and Return On Equity of -11.22 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Brainstorm Cell's valuation include:
Price Book 65.8173 | Enterprise Value 10.6 M | Enterprise Value Ebitda (1.70) |
Overvalued
Today
Please note that Brainstorm Cell's price fluctuation is dangerous at this time. Calculation of the real value of Brainstorm Cell Ther is based on 3 months time horizon. Increasing Brainstorm Cell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Brainstorm Cell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brainstorm Stock. However, Brainstorm Cell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.74 | Real 1.67 | Target 5.25 | Hype 1.74 | Naive 2.34 |
The intrinsic value of Brainstorm Cell's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Brainstorm Cell's stock price.
Estimating the potential upside or downside of Brainstorm Cell Therapeutics helps investors to forecast how Brainstorm stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brainstorm Cell more accurately as focusing exclusively on Brainstorm Cell's fundamentals will not take into account other important factors: When choosing an evaluation method for Brainstorm Cell Ther, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Brainstorm Cell Cash |
|
Brainstorm Valuation Trend
Brainstorm Cell's real value analysis enables investors to forecast the earnings more efficiently. Using both Brainstorm Cell's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Brainstorm Cell Total Value Analysis
Brainstorm Cell Therapeutics is currently expected to have valuation of 10.6 M with market capitalization of 9.92 M, debt of 672 K, and cash on hands of 12.24 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Brainstorm Cell fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.6 M | 9.92 M | 672 K | 12.24 M |
Brainstorm Cell Asset Utilization
One of the ways to look at asset utilization of Brainstorm is to check how much profit was generated for every dollar of assets it reports. Brainstorm Cell Therapeutics shows a negative utilization of assets of -1.78 percent, losing $0.0178 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Brainstorm Cell Therapeutics shows how unproductive it operates for each dollar spent on its assets.Brainstorm Cell Ownership Allocation
Brainstorm Cell Therapeutics shows 9.0 percent of its outstanding shares held by insiders and 13.89 percent owned by other corporate entities.Brainstorm Cell Profitability Analysis
Net Loss for the year was (17.19 M) with profit before overhead, payroll, taxes, and interest of 0.About Brainstorm Cell Valuation
An absolute valuation paradigm, as applied to Brainstorm Stock, attempts to find the value of Brainstorm Cell Ther based on its fundamental and basic technical indicators. By analyzing Brainstorm Cell's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Brainstorm Cell's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Brainstorm Cell. We calculate exposure to Brainstorm Cell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Brainstorm Cell's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -265 K | -251.8 K | |
| Pretax Profit Margin | 57.18 | 60.04 | |
| Operating Profit Margin | 56.56 | 59.39 | |
| Net Profit Margin | 57.80 | 60.69 | |
| Gross Profit Margin | 0.16 | 0.21 |
Brainstorm Cell Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 43.1 M |
Brainstorm Cell Current Valuation Indicators
Valuation refers to the process of determining the present value of Brainstorm Cell Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Brainstorm we look at many different elements of the entity such as Brainstorm's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Brainstorm Cell, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Brainstorm Cell's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Brainstorm Cell's worth.Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |